PlainPharmaWatch

CMS Open Payments · Program Year 2024

Neos Therapeutics, LP

Neos Therapeutics, LP reported $163,635.99 in payments to 7,979 physicians and teaching hospitals across 7,979 transactions.

See the rankings → How this is sourced
$163.6K
Total payments
7,979
Transactions
7,979
Recipients
−$109.8K
General Payments vs PY2023

Neos Therapeutics, LP reported $163,635.99 in payments to 7,979 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1061 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $20.51 per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Neos Therapeutics, LP pairs below-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#1061
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Neos Therapeutics, LP's CMS-reported General Payments decreased by $109.8K (−40.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: NEOS THERAPEUTICS, LPPY2023: NEOS THERAPEUTICS, LPPY2024: Neos Therapeutics, LP. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$273.4KPY2024$163.6K
PY2023
$273,436.23
PY2024
$163,635.99

How Neos Therapeutics, LP ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Neos Therapeutics, LP's total vs. every reporting company

CMS Open Payments, Program Year 2024

$163,636 45th percentile higher than 45% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). This entry sits in this band. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Neos Therapeutics, LP

Neos Therapeutics, LP ranks #1061 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $163,635.99 across 7,979 transactions to 7,979 physicians and teaching hospitals - $20.51 per transaction and $20.51 per recipient on average.

The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $134.5K, accounting for 82.2% of the company's reported total and 7,953 transactions.

General Payment Breakdown by Type

Across 4 types of general payments, Neos Therapeutics, LP's largest category was "Food and Beverage" at $134.5K - 82.2% of the company's reported total.

How Neos Therapeutics, LP divides its payments

Ranked by total dollars reported per category

1. Food and Beverage$134.5K2. Compensation for Services…$26.1K3. Consulting Fee$1.7K4. Travel and Lodging$1.3K
Payment Type Amount Transactions
Food and Beverage $134.5K 7,953
Compensation for Services Other Than Consulting $26.1K 19
Consulting Fee $1.7K 3
Travel and Lodging $1.3K 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $30,903.53 (18.9%) of $163,635.99 in this company's General Payments records across 3,679 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Neos Therapeutics, LP

The five named recipients with the highest reported General Payments from this company

Michael Feld$19.8KGeorge Bright$4.3KJoseph Gagnon$3.7KBenjamin Epstein$2.3KDavid Ganeles$819.82
  1. 1

    Michael Feld

    $19,793.95 across 36 reported transactions

  2. 2

    George Bright

    $4,292.14 across 9 reported transactions

  3. 3

    Joseph Gagnon

    $3,686.18 across 36 reported transactions

  4. 4

    Benjamin Epstein

    $2,311.44 across 11 reported transactions

  5. 5

    David Ganeles

    $819.82 across 41 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $20.51. Average per recipient: $20.51.

Total Amount

$163,635.99

Avg per Transaction

$20.51

Avg per Recipient

$20.51

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Neos Therapeutics, LP Share

0.0%

#1061 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Neos Therapeutics, LP

GenMark Diagnostics, Inc.

$163.4K 8 recipients

Acist Medical Systems, Inc.

$163.3K 644 recipients

Avertix Medical, Inc

$164.0K 25 recipients

Fresenius USA Manufacturing, Inc.

$163.1K 24 recipients

Lumendi LLC

$164.6K 83 recipients

Resmed Corp

$164.6K 1,167 recipients

Frequently Asked Questions

How much did Neos Therapeutics, LP pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Neos Therapeutics, LP, totaling $163,635.99 across 7,979 transactions to physicians and hospitals.
How many physicians received payments from Neos Therapeutics, LP? ▾
Averaging $20.51 per recipient, Neos Therapeutics, LP's 2024 payments reached 7,979 physicians and teaching hospitals.
What types of payments did Neos Therapeutics, LP make? ▾
4 categories of general payment make up Neos Therapeutics, LP's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Food and Beverage" at $134.5K, representing 82.2% of the company's reported total.
How does Neos Therapeutics, LP rank among pharmaceutical companies? ▾
By total payment amount, Neos Therapeutics, LP sits at #1061 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Neos Therapeutics, LP? ▾
Neos Therapeutics, LP's 7,979 transactions to 7,979 recipients in 2024 averaged $20.51 per transaction.
Where does the payment data for Neos Therapeutics, LP come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Neos Therapeutics, LP's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.